You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW

Article metrics

Article menu

Download PDFPDF

Spondyloarthritis
Original article
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 2020552545256
Jun 2020205203121
Jul 202012412081
Aug 202010310151
Sep 202011611489
Oct 2020121112123
Nov 2020150151110
Dec 2020918369
Jan 202111911574
Feb 202113412174
Mar 202112811289
Apr 2021696744
May 20211009839
Jun 2021928831
Jul 2021696726
Aug 2021777428
Sep 2021656239
Oct 2021787444
Nov 2021504630
Dec 2021737330
Jan 2022585515
Feb 2022656117
Mar 2022888633
Apr 2022686217
May 2022535220
Jun 2022525120
Jul 2022615513
Aug 2022748525
Sep 2022949234
Oct 2022827821
Nov 2022888813
Dec 2022403812
Jan 2023615315
Feb 2023858527
Mar 2023595419
Apr 2023252518
May 2023505021
Jun 202352517
Jul 2023736620
Aug 202338378
Sep 202349397
Oct 2023645612
Nov 202338364
Dec 2023313016
Jan 202423207
Feb 2024423618
Mar 2024585598
Total408739221985